Seagen Inc.

$228.74 -0.07%
NASDAQ: SGEN
Market Cap.: 43.2 B L
P/E: -57.19 x3.3
EPS: -4.00 x 5.9
Earnings Call
No. The last one was 8 months, 3 weeks ago
Dividend Waiting Time
n.A.
Latest Dividends History
Yield
Payout
Volume Level
μ 1,634,027
19,392,808 Moderate Low
Performance Ranks (Intraday)
United States:

1470th

out of

2160

Healthcare:

458th

out of

792

Biotechnology:

151st

out of

227

Peer Group:

10th

out of

13

About

Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin …